Video Experimental Relacionado
Updated: May 10, 2025

10:46
Gene Digital Circuits Based on CRISPR-Cas Systems and Anti-CRISPR Proteins
Published on: October 18, 2022
1.6K
Inhibición de CRISPR-Cas13 mediada por ARN a través de la imitación estructural del ARNcr
Victoria M Hayes1, Jun-Tao Zhang2, Mark A Katz1
1Department of Microbiology, University of Washington, Seattle, WA, USA.
Resumen
Los investigadores descubrieron un nuevo ARN anti-CRISPR (rAcr) llamado rAcrVIA1 que inhibe los sistemas CRISPR-Cas13. Este ARN utiliza la imitación estructural, no la similitud de secuencias, para bloquear la inmunidad bacteriana, expandiendo la diversidad conocida de mecanismos anti-CRISPR.
Área de la Ciencia:
- Biología molecular
- Genética microbiana
- Biología estructural
Sus antecedentes:
- Los fagos bacterianos usan factores anti-CRISPR (ACR) para evadir la inmunidad adaptativa de CRISPR-Cas.
- Si bien la mayoría de los ACR son proteínas, han surgido los ACR de ARN (rAcr), que imitan a los ARN CRISPR (crRNA) para inhibir las nucleasas Cas.
- Comprender los diversos mecanismos de ACR es crucial para el aprovechamiento de los sistemas CRISPR-Cas.
Objetivo del estudio:
- Descubrir y caracterizar nuevos ARN anti-CRISPR (rAcrs) dirigidos a los sistemas CRISPR-Cas.
- Investigar el mecanismo de inhibición empleado por un rAcr codificado por plásmido recientemente identificado en Listeria seeligeri.
- Para aclarar la base estructural de la evasión inmune basada en el ARN en las bacterias.
Principales métodos:
- Identificación y clonación de un ARN pequeño codificado por plásmido, rAcrVIA1, de Listeria seeligeri.
- Ensayos bioquímicos para confirmar la actividad inhibidora de rAcrVIA1 contra el sistema CRISPR-Cas13.
- Microscopía crioelectrónica (cryo-EM) para determinar la estructura del complejo Cas13-rAcrVIA1.
Principales resultados:
- Descubrimiento de rAcrVIA1, un pequeño ARN codificado por plásmido que inhibe el sistema CRISPR-Cas13 dirigido al ARN.
- El análisis estructural reveló que rAcrVIA1 adopta un pliegue muy similar al crRNA.
- La inhibición por rAcrVIA1 ocurre a pesar de la mínima homología de secuencia con el crRNA, lo que indica una imitación estructural.
Conclusiones:
- Los hallazgos amplían el repertorio conocido de ARN anti-CRISPR (rAcrs).
- rAcrVIA1 proporciona un nuevo ejemplo de antagonismo inmune mediado por la imitación estructural del ARN.
- Este descubrimiento pone de relieve las diversas estrategias que las bacterias y los fagos emplean en su carrera armamentista molecular.
Videos de Conceptos Relacionados
CRISPR
48.5K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
48.5K
CRISPR and crRNAs
16.3K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
16.3K
RNA Interference
25.8K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
25.8K
Experimental RNAi
6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
Types of RNA
62.6K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
62.6K
Homologous Recombination
49.7K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
49.7K

